Instil Bio, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Instil Bio, Inc. Common Stock (TIL) has a 3-month relative strength percentile of 25 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.1%, relative volume 1.09×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
25 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
TIL is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -7.4% / -33.5%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
TIL is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $980K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $980K |
| VXFVanguard Extended Market ETF | 0.00% | $344K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TIL Jan avg: 16.21% median: 22.90% win: 75% σ: 38.16% n: 4 2022-04-12 → 2026-05-29 | TIL Feb avg: 3.21% median: -1.75% win: 50% σ: 15.85% n: 4 2022-04-12 → 2026-05-29 | TIL Mar avg: -11.35% median: -11.51% win: 0% σ: 3.54% n: 4 2022-04-12 → 2026-05-29 | TIL Apr avg: -10.46% median: -3.16% win: 20% σ: 12.58% n: 5 2022-04-12 → 2026-05-29 | TIL May avg: 17.28% median: -1.20% win: 40% σ: 52.07% n: 5 2022-04-12 → 2026-05-29 | TIL Jun avg: -14.42% median: -15.43% win: 0% σ: 9.95% n: 4 2022-04-12 → 2026-05-29 (current) | TIL Jul avg: 13.69% median: 16.79% win: 75% σ: 10.13% n: 4 2022-04-12 → 2026-05-29 | TIL Aug avg: 0.46% median: 2.35% win: 50% σ: 15.59% n: 4 2022-04-12 → 2026-05-29 | TIL Sep avg: 84.17% median: -6.02% win: 25% σ: 199.37% n: 4 2022-04-12 → 2026-05-29 | TIL Oct avg: -24.79% median: -22.57% win: 0% σ: 22.52% n: 4 2022-04-12 → 2026-05-29 | TIL Nov avg: -27.83% median: -21.48% win: 0% σ: 22.65% n: 4 2022-04-12 → 2026-05-29 | TIL Dec avg: -20.76% median: -21.43% win: 25% σ: 27.30% n: 4 2022-04-12 → 2026-05-29 |